Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Leuk Lymphoma. 2019 Feb 7;60(9):2190–2198. doi: 10.1080/10428194.2019.1574002

Table 1.

Patient characteristics by trial enrollment status.

Total N = 370 (%) Enrolled N= 206 (%) Not enrolled N = 164 (%)
Race/Ethnicity
 Non-Hispanic White 198 (53) 121 (59) 77 (47)
 Non-Hispanic Black 48 (13) 15 (7) 33 (20)
 Hispanic 72 (19) 43 (21) 29 (18)
 Other 52 (14) 27 (13) 25 (15)
Sex
 Female 180 (49) 98 (48) 82 (50)
 Male 190 (51) 108 (52) 82 (50)
Age, years
 0–1 42 (12) 15 (7) 27 (17)
 1–5 87 (23) 54 (26) 33 (20)
 5–10 69 (18) 37 (18) 32 (19)
 10–15 83 (22) 52 (25) 31 (19)
 >15 89 (24) 48 (23) 41 (25)
Insurance type
 Private 168 (45) 94 (46) 74 (44)
 Public 178 (48) 97 (47) 81 (49)
 Other 24 (6) 15 (7) 9 (5)
Acuity at Presentation
 No ICU 330 (90) 187 (91) 143 (87)
 1 system 24 (6) 14 (6.1) 10 (6.8)
 2 or more systems 16 (4) 5 (2.4) 11 (6.7)
Region
 South 124 (34) 62 (30) 62 (38)
 Midwest 98 (26) 50 (24) 48 (28)
 Northeast 50 (14) 31 (15) 19 (12)
 West 98 (26) 63 (31) 35 (21)
Zip-based Poverty
 <4% population below FPL 81 (22) 37 (18) 44 (28)
 ≥4% population below FPL 281 (73) 165 (82) 116 (73)
Zip-based Low Education
 <11% without HS diploma 91 (25) 44 (22) 47 (29)
 ≥11% without HS diploma 275 (75) 158 (78) 113 (71)
Year
 2011 40 (11) 21 (10) 19 (11)
 2012 134 (36) 82 (40) 52 (31)
 2013 140 (38) 68 (33) 72 (44)
 2014 56 (15) 35 (17) 21 (13)